Quick Answer
HERON THERAPEUTICS, INC. /DE/ reported Research And Development Expense of $12.43 million for the year ending 2025.
- HERON THERAPEUTICS, INC. /DE/ showed a decrease of -25.5% in Research And Development Expense from 2024 to 2025.
- This data is from HERON THERAPEUTICS, INC. /DE/'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), HERON THERAPEUTICS, INC. /DE/'s Research And Development Expense has grown by 59.4%.
- Historical annual values: Fiscal year 2025: $12.43 million | Fiscal year 2024: $16.68 million | Fiscal year 2023: $39.13 million | Fiscal year 2022: $82.70 million | Fiscal year 2021: $130.82 million | Fiscal year 2020: $174.53 million | Fiscal year 2019: $167.38 million | Fiscal year 2018: $140.03 million | Fiscal year 2017: $138.58 million | Fiscal year 2016: $103.13 million | Fiscal year 2015: $61.18 million | Fiscal year 2014: $54.83 million | Fiscal year 2013: $32.52 million | Fiscal year 2012: $15.17 million | Fiscal year 2011: $8.21 million | Fiscal year 2010: $7.26 million | Fiscal year 2009: $7.80 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: